The Claim
Among patients with gout in primary care settings, the proportion achieving serum uric acid levels below 0.36 mmol/L is approximately 38–43%, indicating that biochemical control remains suboptimal despite widespread use of allopurinol.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In primary care, about 38% to 43% of gout patients have serum uric acid levels below 0.36 mmol/L, even though most are prescribed allopurinol.
See the scientific wording
In primary care, the baseline proportion of gout patients achieving serum uric acid levels below 0.36 mmol/L is approximately 38–43%, indicating widespread suboptimal biochemical control despite widespread allopurinol prescribing.
The body produces too much uric acid or does not remove it fast enough, and the medicine used to block uric acid production does not work strongly enough in most patients to bring levels down to the target range.
What the research says
1 studyEven though many gout patients take medicine to lower uric acid, only about 4 out of 10 have it low enough to prevent attacks — and this study found the same thing. It also showed that helping patients understand their medicine can improve that number, but the original problem is real.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.